This is a branding and awareness initiative with no immediate financial implications. Traders should monitor for future updates on commercial or clinical progress, but this release alone is unlikely to move the stock meaningfully.
Price Chart
Executive Summary
Invivyd launched a national education campaign called 'Antibodies for Any Body' in partnership with ski champion Lindsey Vonn to raise public awareness about antibodies and immune health. The campaign features a dedicated website with an interactive wellness assessment tool to help individuals understand how lifestyle habits influence immune function. This is a promotional initiative and does not involve a commercial product launch or financial transaction.
Key Facts
- Invivyd launched a public education campaign focused on antibodies and immune health.
- The campaign includes a partnership with Olympic skier Lindsey Vonn.
- A new website, AntibodiesforAnyBody.com, offers an interactive immune health assessment tool.
- No financial figures, product sales, or clinical data were disclosed in the release.
- The announcement is promotional and includes forward-looking statements with no material financial impact.
Financial Impact
No direct financial impact disclosed; campaign is educational and brand-building in nature.
Risk Factors
- Forward-looking statements are subject to risks including execution risk for the campaign.
- No assurance the campaign will lead to increased product adoption or revenue.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3268977 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $0.8800 $0.8441 | ▼ −4.08% | ▼ −5.26% | $0.8221 (−6.58%) |
Aug 17, 2026 6w ago | 144 | $0.8680 $0.8198 | ▼ −5.55% | ▼ −4.56% | $0.8221 (−5.29%) |
Jul 6, 2026 12w ago | 8-K | $0.8340 $0.5350 | ▲ +35.85% | ▲ +35.29% | $0.8221 (+1.43%) |
Jun 16, 2026 15w ago | Press Release | $0.8918 $0.8008 | ▼ −10.20% | ▼ −10.40% | $0.8221 (−7.82%) |
Jun 11, 2026 16w ago | Institutional Cluster | $0.8125 $0.8037 | ▼ −1.08% | ▼ −2.97% | $0.8221 (+1.18%) |
Jun 9, 2026 16w ago | Press Release | $0.9900 $0.9418 | ▼ −4.87% | ▼ −6.32% | $0.8221 (−16.96%) |
Jun 1, 2026 17w ago | Press Release | $1.22 $0.8724 | ▼ −28.49% | ▼ −27.19% | $0.8221 (−32.61%) |
May 14, 2026 20w ago | 8-K | $1.16 $0.7700 | ▼ −33.62% | ▼ −32.76% | $0.8221 (−29.13%) |
May 14, 2026 20w ago | Press Release | $1.16 $0.7700 | ▼ −33.62% | ▼ −32.76% | $0.8221 (−29.13%) |
Apr 9, 2026 25w ago | 8-K | $1.78 $1.46 | ▼ −17.98% | ▼ −25.55% | $0.8221 (−53.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access